Your search for "" did not match any of our events. Please try another event term or combination of terms and filters.
| September 28, 2023 |
| 5:00 - 6:00 PM |
| Pelton Auditorium |
Prostate Cancer Theranostics |
| Wolfgang Weber, MD |
| Chair, Department of Nuclear Medicine |
| Technical University Munich |
| October 5, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| When the Square Became a Sphere: A Pathologist’s Journey |
| Lawrence True, MD |
| Professor of Pathology |
| University of Washington |
| October 12, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Clinical Biomarkers and Immune Checkpoint Inhibitors (ICI) in Advanced Urothelial Carcinoma |
| Dimitra Bakaloudi, PhD |
| Postdoctoral Research Fellow |
| University of Washington |
| October 19, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Michael Haffner, MD, PhD |
| Assistant Professor, Human Biology Division |
| Fred Hutchinson Cancer Center |
| November 2, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Wayne Tilley, PhD |
| Director, Dame Roma Mitchell Cancer Research Laboratories |
| University of Adelaide |
| November 9, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Colin Pritchard, MD, PhD |
| Director, Genetics & Solid Tumors Laboratory |
| University of Washington |
| November 16, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| November 30, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Michael Schweizer, MD |
| Assistant Professor, Division of Medical Oncology |
| University of Washington |
| December 7, 2023 |
| 5:00 - 6:00 PM |
| Pelton Auditorium |
Title TBD |
| Kent Mouw, MD, PhD |
| Assitant Professor, Radiation Oncology |
| Harvard Medical School |
|
|||||||||
| December 21, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| January 4, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Elizabeth Keohne, MD |
| Acting Instuctor, Urologic Oncology |
| University of Washington |
|
|
| 5:00 - 6:00 PM | |
| Sze Conference Suite | |
| Title TBD |
| January 18, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| January 25, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| February 1, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Evan Yu, MD |
| Professor, Division of Hematology and Oncology |
| University of Washington |
| February 8, 2024 |
| 5:00-6:00 PM |
| Sze Conference Suite |
| Title TBD |
| February 15, 2024 |
| 5:00 - 6:00 PM |
| Pelton Auditorium |
Title TBD |
| Veda Giri, MD, PhD |
| Division Chief, Clinical Cancer genetics |
| Yale School of Medicine |
| February 22, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Amir Iravani, MD |
| Associate Professor of Radiology |
| University of Washington |
| February 29, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| March 7, 2024 |
| 5:00 - 6:00 PM |
| Pelton Auditorium |
Title TBD |
| Joshua Meeks, MD, PhD |
| Associate Professor of Urology, Biochemisty and Molecular Genetics |
| Northwestern University Feinberg School of Medicine |
| March 14, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| March 21, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| March 28, 2023 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| April 4, 2024 |
| 5:00 - 6:00 PM |
| Pelton Auditorium |
Title TBD |
| David Solit, MD |
| Professor of Medicine |
| Memorial Sloan-Kettering Cancer Center |
| April 11, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| April 18, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| April 25, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| May 2, 2024 |
| 5:00 - 6:00 PM |
| Pelton Auditorium |
Title TBD |
| Matthew Galsky, MD |
| Professor of Hematology and Oncology |
| Mount Sinai |
| May 9, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| May 16, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Jessica Hawley, MD, MS |
| Assistant Professor of Hematology and Oncology |
| University of Washington |
| May 23, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| May 30, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
| June 6, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
Title TBD |
| Jonathan Wright, MD, MD, FACS |
| Professor of Urology |
| University of Washington |
|
||
| Sze Conference Suite | ||
| Title TBD |
| June 20, 2024 |
| 5:00 - 6:00 PM |
| Sze Conference Suite |
| Title TBD |
Click titles to view recent seminars.
| September 21, 2023 |
| Peter S. Nelson, MD |
| Director, Pacific Northwest Prostate Cancer SPORE |
| Fred Hutchinson Cancer Center |
| June 1, 2023 |
| Phase II Trial of Pembrolizumab with Neutron Radiation in Advanced Urothelial Carcinoma + Updates on Ultra-high Dose Rate Radiation (FLASH) Research |
| Jing Zeng, MD |
Associate Professor, University of Washington |
| May 25, 2023 |
| Nondestructive 3D Pathology and Analysis for Precision Medicine |
| Jonathan Liu, PhD |
Professor, University of Washington |
| May 18, 2023 |
| Characterizing Personalized Risk Vs. Resiliency & the Development of a Prehabilitation Program for Patients with Urologic Cancers |
| Joshi Alumkal, MD |
Professor, University of Michigan |
May 11, 2023 |
Community-Partnered and Patient-Centered Approaches to Addressing Inequities in Prostate Cancer Care among Black Individuals |
Yaw Nyame, MD, MS, MBA |
Assistant Professor, Fred Hutchinson Cancer Center |
| May 4, 2023 |
| Characterizing Personalized Risk Vs. Resiliency & the Development of a Prehabilitation Program for Patients with Urologic Cancers |
| Sarah Psutka, MD |
Associate Professor, University of Washington |
| April 27, 2023 |
| Exploiting DNA Damage Repair Alterations in Advanced Prostate Cancer |
| Heather Cheng, MD, PhD |
Assistant Professor, University of Washington |
| April 20, 2023 |
| Biomolecular Condensates and Stress Adaptation in Cancer |
| Syam Somasekharan, PhD |
Assistant Professor, University of British Columbia |
| April 13, 2023 |
| Exploiting DNA Damage Repair Alterations in Advanced Prostate Cancer |
| Ruben Raychaudhuri, PhD |
Post-Doctoral Fellow, Fred Hutch |
| April 6, 2023 |
| Urologic Cancer Care in the WWAMI Catchment |
| John Gore, MD |
| Professor, University of Washington |
| March 30, 2023 |
| Common and Rare Germline Genetic Contributions to Overall and Aggressive Prostate Cancer Risk |
| Elizabeth Wasmuth, PhD |
| Assistant Professor, University of Texas San Antonio |
| March 23, 2023 |
| Leveraging Insights into PSMA Biology to Optimize PSMA Directed Therapies |
| Michael Haffner, MD, PhD |
| Assistant Professor, Fred Hutchinson Cancer Center |
| March 9, 2023 |
| Improving Quality in Cancer Care: Addressing Access to Care and Reducing Disparities in GU Oncology |
| Evan Yu, MD |
| Assistant Professor, University of Washington |
| Click here to view the seminar |
| March 2, 2023 |
| New Approaches in the Treatment of Bladder Cancer |
| Jonathan Rosenberg, MD |
| Chief, GU Oncology, Memorial Sloan Kettering Cancer Center |
| February 23, 2023 |
| Effects of the Great Oxygenation Event and Other Metabolic Interventions for Prostate Cancer |
| Stephen Plymate, MD |
| Professor, University of Washington |
| February 16, 2023 |
| Common and Rare Germline Genetic Contributions to Overall and Aggressive Prostate Cancer Risk |
| Burcu Darst, PhD |
| Assistant Professor, Fred Hutchinson Cancer Center |
| February 9, 2023 |
| Association of Steroid Levels with Response to Hormonal Vs. Chemo-Hormonal therapy in Prostate Cancer |
| Elahe Mostaghel, MD, PhD |
| Associate Professor, University of Washington |
| Click here to view the seminar |
| February 2, 2023 |
| The Dilemma of T1 NBIBC |
| Sima Porten, MD, MPH |
| Associate Professor, University of California San Francisco |
| January 26, 2023 |
| Bipolar Androgen Therapy v2.0: Updates and Future Directions |
| Michael Schweizer, MD |
| Associate Professor, University of Washington |
| Click here to view the seminar |
| January 19, 2023 |
| Exploration of Novel Therapy for Patients with Thoracic and GU Cancers |
| Lingbin Meng, MD, PhD |
| Moffitt Cancer Center |
| January 12, 2023 |
| Improving Quality in Cancer Care: Addressing Access to Care and Reducing Disparities in GU Oncology |
| Hiba Khan, MD |
| Fred Hutch |
| Click here to view the seminar |
| January 5, 2023 |
| Variant Histology |
| Fed Ghali, PhD and Rafee Talukder, PhD |
| University of Washington |
| Click here to view the seminar |
| December 15, 2022 |
| Chromatin Variants Identify Cancer Drivers in the Repetitive Genome |
| Mathieu Lupien, PhD |
| Professor, University of Toronto |
| Click here to view the seminar |
| December 8, 2022 |
| Tumor Cell-intrinsic and Extrinsic Determinants for Prostate Cancer Aggressiveness |
| Li Xin, PhD |
| Professor, University of Washington |
| Click here to view the seminar |
| November 17, 2022 |
| Effects of Fluid Shear Stress on Circulating Tumor Cells |
| Michael Henry, PhD |
| Professor, University of Iowa |
| Click here to view the seminar |
| November 3, 2022 |
| The Transformative Journey Towards Precision Pathology: Challenges and Opportunities |
| George Netto, MD |
| Professor, University of Alabama Birmingham |
| Click here to view the seminar |
| October 20, 2022 |
| Deciphering and Exploiting Genomic and Metabolic Alterations in Prostate Cancer |
| Ian Mills, PhD |
| Professor, University of Oxford |
| Click here to view the seminar |
| October 13, 2022 |
| New Therapeutic Discoveries and Mechanisms for Castrate Resistant Prostate Cancer |
| Kathleen Kelly, PhD |
| Chief, Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute |
| Click here to view the seminar |
| October 6, 2022 |
| Updates on the UW/Fred Hutch bladder cancer program; Bladder Cancer Rapid Autopsy |
| Andrew Hsieh, MD, and Ming Lam, PhD |
| University of Washington/Fred Hutch |
| Click here to view the seminar |
| September 29, 2022 |
| Modelling and Targeting CRPC or NEPC progression from Hormone-Naïve Prostate Cancer |
| Yuzhuo Wang, PhD, FCAHS, |
| Distinguished Scientist, BC Cancer Research Center |
| Click here to view the seminar |
| September 22, 2022 |
| Dual Targeting of HDAC and PI3K in Metastatic Castration-Resistant Prostate Cancer |
| John K. Lee, MD, PhD |
| Assistant Professor, Fred Hutchinson Cancer Center/University of Washington |
| Click here to view the seminar |
| September 15, 2022 |
| Prostate Cancer 2022: The Bright Road Ahead |
| Matthew Cooperberg, MD, MPH |
| Professor, University of California San Francisco |
| September 8, 2022 |
| Building a Prostate Cancer Dependency Map |
| Peter Nelson, MD |
| Director, Pacific Northwest Prostate Cancer SPORE |
| Click here to view the seminar |
June 23,2022
Defining the Roles of Genetic Factors in the Cellular Reprogramming of Androgen Receptor-Active Prostate Cancer to Neuroendocrine Prostate Cancer Shan Li, PhD Post-Doctoral Research Fellow, Fred Hutchinson Cancer Center
June 23, 2022
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer Reza Ghodsi, PhD Post-Doctoral Research Fellow, Fred Hutchinson Cancer Center
June 16, 2022
2022 ASCO Updates Michael Schweizer, MD Assistant Professor, University of Washington
June 9, 2022
Androgen Receptor Regulation of Luminal and Non-Luminal Cell Identities in Prostate Cancer Stephanie Harmon, PhD Staff Scientist, National Institutes of Health
June 2, 2022
ADUX4 and the Elusive Cancer Stem Cell Stephen Tapscott, MD, PhD Professor, Fred Hutchinson Cancer Center
May 26, 2022
Androgen Receptor Regulation of Luminal and Non-Luminal Cell Identities in Prostate Cancer Scott Dehm, PhD Assistant Professor, University of Minnesota
May 12, 2022
HOXB13 Alters Chromatin Accessibility in Prostate Cancer Through Interactions with the SWI/SNF Complex Nathan Lack, PhD Assistant Professor, University of British Columbia
May 5, 2022
Exploring Bladder Cancer Biology in Mouse and Man William Kim, MD Professor, University of North Carolina
April 28, 2022
Architectural Diversity of Prostate Cancer Bone Metastasis Michael Cox, PhD Professor, University of British Columbia
April 21, 2022
The Microbiome as a Mediator of Prostate Carcinogenesis Karen Sfanos, MS, PhD Associate Professor, Johns Hopkins Medicine
April 14, 2022
Overcoming Resistance Mechanisms of AR-targeted Therapy Allen Gao, MD, PhD Professor, University of California Davis
April 7, 2022
The Golden Age is Now — The Evolution of Multidisciplinary Care in Non-Muscle Invasive Bladder Cancer
Noah M. Hahn, M.D.
Professor, Johns Hopkins Greenberg Bladder Cancer Institute
March 17, 2022
Cellular Heterogeneity in the Therapeutic Resistance and Disease Progression of Prostate Cancer – A Pathologist’s Perspective Jiaoti Huang, MD, PhD Professor, Duke University
March 10, 2022
Protein Control Using Targeted Degradation Approaches Benham Nabet, PhD Assistant Professor, Fred Hutchinson Cancer Center
March 3, 2022
The (R)evolution in Urothelial Cancer Treatment Changng Practice via Collaborative Research
Petros Grivas, M.D., Ph.D.
Associate Professor, Division Medical Oncology, University of Washington
Associate Professor, Clinical Research Division, Fred Hutch
February 17, 2022
Novel Insights in Prostate Cancer Growth Hannelore Heemers, PhD Associate Staff, Cleveland Clinic/Lerner Research Institute
February 10, 2022
Germline Genetic Factors as Predictors of Prostate Cancer Risk in Multi-Ancestry Populations Burcu Darst, PhD Assistant Professor, Fred Hutchinson Cancer Center
February 3, 2022
Investigating Genetic Determinants of Bladder Cancer and New Therapeutic Approaches John K. Lee, MD, PhD Assistant Professor, Fred Hutchinson Cancer Center
January 27, 2022
Functional Genomics of Untranslated Regions in Prostate Cancer Samantha Schuster PhD Candidate, University of Washington Andrew Hsieh MD Associate Professor, Fred Hutchinson Cancer Center
January 20, 2022
Precision Medicine with DNA-targeted Therapies Yves Pommier, MD, PhD Principal Investigator, National Institutes of Health
January 13, 2022
TP53 Germline Mutations Are Associated with Prostate Cancer Kara Maxwell, MD, PhD Associate Professor, Penn Medicine Colin Pritchard, MD, PhD Director, Genetics and Solid Tumors Laboratory, University of Washington
January 6, 2022
mTOR Signaling Effects in Urothelial Carcinoma Donna Hansell, MD, PhD Professor, Oregon Health and Science University
December 2, 2021
Artificial General Intelligence: A Profoundly Disruptive Approach to Unmet Needs in Health and Wellness. Craig Mundie CEO, Mundie &Associates
November 18, 2021
Phenotype to Targeted Therapy: Problems and Pathways to Drug Development Stephen Plymate, MD Professor, University of Washington
November 4, 2021
Exploiting Urine Derived DNA for the Assessment of Bladder Cancer Using High Accuracy Sequencing
Scott R. Kennedy, Ph.D.
Assistant Professor, University of Washington
October 21, 2021
Developmental Pathways and Prostate Cancer: The Role of HOXB13 Binding Partners in Prostate Progression Donald Vander Griend, PhD Associate Professor, University of Illinois at Chicago
October 14, 2021
Longitudinal Single-Cell Analysis Of Metastases From Men With mHSPC Treated with ADT and Anti-PD1 Jessica Hawley, MD Assistant Professor, Fred Hutchinson Cancer Center
October 7, 2021
Germline-Somatic Interactions in UC Genomes Bishoy Faltas, MD Assistant Professor, Weill Cornell Medicine
September 30, 2021
Widening the aperture: A role for T cell intrinsic androgen receptor activity Amy Moran, PhD Associate Professor, Oregon Health and Science University
September 23, 2021
Cellular Plasticity in Prostate Cancer Treatment Resistance Amina Zoubeidi, PhD Professor, University of British Columbia
September 16, 2021
Deciphering the Mechanism of Lineage Plasticity-Driven AR Therapy Resistance at Single Cell Resolution Ping Mu, PhD Assistant Professor, UT Southwestern Medical Center
September 9, 2021
Convergent Evolution and the Origins of Lethal Cancer: the Polyaneuploid Cancer Cell State Kenneth Pienta, MD Professor, Johns Hopkins Medicine
September 2, 2021
Molecular Classification of Prostate Cancer: Insights for Precision Oncology
Pete Nelson, MD Director, Pacific Northwest Prostate Cancer SPORE